BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25290089)

  • 1. IRAK signalling in cancer.
    Rhyasen GW; Starczynowski DT
    Br J Cancer; 2015 Jan; 112(2):232-7. PubMed ID: 25290089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling.
    Flannery S; Bowie AG
    Biochem Pharmacol; 2010 Dec; 80(12):1981-91. PubMed ID: 20599782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling.
    Kawagoe T; Sato S; Jung A; Yamamoto M; Matsui K; Kato H; Uematsu S; Takeuchi O; Akira S
    J Exp Med; 2007 May; 204(5):1013-24. PubMed ID: 17485511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor cross-hyporesponsiveness is functional in interleukin-1-receptor-associated kinase-1 (IRAK-1)-deficient macrophages: differential role played by IRAK-1 in regulation of tumour necrosis factor and interleukin-10 production.
    Berglund M; Thomas JA; Hörnquist EH; Hultgren OH
    Scand J Immunol; 2008 May; 67(5):473-9. PubMed ID: 18405325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
    Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
    Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase M.
    Wu Q; Jiang D; Smith S; Thaikoottathil J; Martin RJ; Bowler RP; Chu HW
    J Allergy Clin Immunol; 2012 Mar; 129(3):825-833.e2. PubMed ID: 22154382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRAK family in inflammatory autoimmune diseases.
    Su LC; Xu WD; Huang AF
    Autoimmun Rev; 2020 Mar; 19(3):102461. PubMed ID: 31917263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRAK-4 inhibitors for inflammation.
    Wang Z; Wesche H; Stevens T; Walker N; Yeh WC
    Curr Top Med Chem; 2009; 9(8):724-37. PubMed ID: 19689377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity.
    Liu G; Tsuruta Y; Gao Z; Park YJ; Abraham E
    J Immunol; 2007 Sep; 179(6):4125-34. PubMed ID: 17785851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRAK-4--a shared NF-kappaB activator in innate and acquired immunity.
    Suzuki N; Saito T
    Trends Immunol; 2006 Dec; 27(12):566-72. PubMed ID: 17046325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells.
    Song KW; Talamas FX; Suttmann RT; Olson PS; Barnett JW; Lee SW; Thompson KD; Jin S; Hekmat-Nejad M; Cai TZ; Manning AM; Hill RJ; Wong BR
    Mol Immunol; 2009 Apr; 46(7):1458-66. PubMed ID: 19181383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRAK Inhibitor Protects the Intestinal Tract of Necrotizing Enterocolitis by Inhibiting the Toll-Like Receptor (TLR) Inflammatory Signaling Pathway in Rats.
    Hou Y; Lu X; Zhang Y
    Med Sci Monit; 2018 May; 24():3366-3373. PubMed ID: 29784900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights from vaccinia virus into Toll-like receptor signalling proteins and their regulation by ubiquitin: role of IRAK-2.
    Bowie AG
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):449-52. PubMed ID: 18481979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity.
    Gan L; Li L
    Immunol Res; 2006; 35(3):295-302. PubMed ID: 17172653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of IRAK-4 in grouper (Epinephelus coioides) that impairs MyD88-dependent NF-κB activation.
    Li YW; Mo XB; Zhou L; Li X; Dan XM; Luo XC; Li AX
    Dev Comp Immunol; 2014 Jul; 45(1):190-7. PubMed ID: 24631582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of tumor necrosis factor and interleukin-1-dependent NF-kappaB activity by mPLK/IRAK.
    Vig E; Green M; Liu Y; Donner DB; Mukaida N; Goebl MG; Harrington MA
    J Biol Chem; 1999 May; 274(19):13077-84. PubMed ID: 10224059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling.
    Moynagh PN
    Trends Immunol; 2009 Jan; 30(1):33-42. PubMed ID: 19022706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis.
    Wiese MD; Manning-Bennett AT; Abuhelwa AY
    Expert Opin Investig Drugs; 2020 May; 29(5):475-482. PubMed ID: 32255710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease.
    Cui JG; Li YY; Zhao Y; Bhattacharjee S; Lukiw WJ
    J Biol Chem; 2010 Dec; 285(50):38951-60. PubMed ID: 20937840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif.
    Abu-Dayyeh I; Shio MT; Sato S; Akira S; Cousineau B; Olivier M
    PLoS Negl Trop Dis; 2008; 2(12):e305. PubMed ID: 19104650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.